Cizzle (LSE:CIZ) Wins US Patent For Its Lung Cancer Blood Test — Does That Change The Commercial Runway?

Cizzle (LSE:CIZ) Wins US Patent For Its Lung Cancer Blood Test — Does That Change The Commercial Runway? →

Highlights United States patent granted covering the group's biomarker blood test technology. North American licensing partner has been widening its laboratory network. Shares reacted positively to the intellectual property milestone. Cizzl…